Sandra Sanabria Bohórquez

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 702 citations · Full text

Oncologic Imaging, Pd-l1 Blockade, Medicine +11

[¹⁸F]MK-9470, a positron emission tomography (PET) tracer for<i>in vivo</i>human PET brain imaging of the cannabinoid-1 receptor

H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez et al. · Proceedings of the National Academy of Sciences · 2007 · 311 citations · Full text

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Obesity, Metabolic Syndrome, Caloric Restriction +11

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink et al. · JAMA Neurology · 2022 · 197 citations · Full text

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

Ngozi Erondu, Ira Gantz, Bret J. Musser et al. · Cell Metabolism · 2006 · 181 citations · Full text

Obesity, Metabolic Syndrome, Meaningful Weight Loss +12